Browse studies

Find your next paid study

27,370 recruiting studies available now

Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy

For children with severe cerebral palsy, a powered wheelchair (PWC) may provide their only option for functional mobility and independence. PWC use is often re…

Cerebral Palsy

Estimated

~$10 – $750

Actual pay is set by the research site.

Grand Valley State UniversityNCT06347432

Phase 4

Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting

The purpose of this study is to evaluate whether or not adding lumateparone to current antidepressant treatment in adults with major depressive disorder experi…

Blunted Emotion in Major Depressive Disorder

Estimated

~$25 – $1,400

Actual pay is set by the research site.

Future Options Research, LLCNCT07824206

Parkinson's Foundation PD GENEration Genetic Registry

Development of a central repository for PD-related genomic data for future research.

Parkinson's Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Parkinson's FoundationNCT04994015

Breast Cancer-Minimal/Molecular Residual Disease Detection and Therapy Monitoring in Patients with Early Stage TNBC-Phase I (B-STRONGER-I)

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided te…

TNBC - Triple-Negative Breast CancerMinimal Residual Disease

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Personalis Inc.NCT06230185

Phase 2

Immuno-consolidation for Newly Diagnosed Multiple Myeloma Using Lack of MRD Negativity After Initial cOmbination Therapy to Pursue Deeper Responses With Linvoseltamab ANd Delay Transplant

The purpose of this study is to determine whether Linvoseltamab therapy in patients with newly diagnosed multiple myeloma will convert the disease status from …

Multiple Myeloma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Dickran Kazandjian, MDNCT06376526

Observational

Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism

The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with …

HyperlipidemiasDiabetesDepression+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Massachusetts, WorcesterNCT06903897

Phase 3

Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma (NDMM)

The purpose of the study is to determine the best treatment approach based on the risk profile of the cancer cells and on how the disease responds to treatment…

Multiple Myeloma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT07624513

Phase 2

A Phase II Multi-Center Open-label Randomized Study of CAPecitabine in Combination With ELAcestrant Versus Capecitabine Alone in Advanced Estrogen Receptor-Positive Breast Cancer (CAPELA)

The goal of this research study is to compare a combination of two drugs, capecitabine and elacestrant to capecitabine alone as a treatment for advanced estrog…

Estrogen-receptor-positive Breast CancerMetastatic Breast CancerBreast Cancer+6 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Kristina A. FanucciNCT07222215

Phase 3

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Study of iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma

This Phase 3 clinical trial is evaluating whether adding iSCIB1+, an investigational DNA-based cancer vaccine, to standard immunotherapy with nivolumab and ipi…

Melanoma (Skin Cancer)Advanced MelanomaMetastatic Melanoma+1 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Scancell LtdNCT07815574

Phase 1

Lidocaine Infusion in Pancreatic Cancer: Translational Studies in a Preclinical Model And Human Subjects

This study elucidates the effects of the intravenous (IV) lidocaine infusion on the biology of pancreatic circulating tumor cells (CTCs) isolated from patients…

Pancreatic Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Illinois at ChicagoNCT04048278

Phase 3

Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth: A Randomized Clinical Trial

This is a Phase 3a, randomized, parallel-controlled trial designed to compare the early re-initiation of semaglutide, starting two weeks after sleeve gastrecto…

Pediatric ObesityMetabolic and Bariatric SurgerySemaglutide

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Children's Hospital Los AngelesNCT06934655

Phase 2

A Phase 2, Randomized, Double-blind, Placebo-controlled Pilot Study Assessing the Efficacy, Safety and Tolerability of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Spasticity in Participants With Post-stroke Spasticity

The goal of this clinical trial is to learn if the drug BMS-986368 works to treat post stroke spasticity in adults who have had a stroke. BMS-986368 is a desig…

Post-Stroke Spasticity

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Alberto EsquenaziNCT07704840